Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3

Diabetologia

Volumn 37, Issue 6, 1994, Pages 552-558

  Mathieu, C ^a   Waer, M ^b   Laureys, J ^a   Rutgeerts, O ^b   Bouillon, R ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Autoimmunity; immunotherapy; insulitis; suppressor cells; vitamin D analogues

Indexed keywords

CALCITRIOL; OSTEOCALCIN;

ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG THERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PREVENTION; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; CALCITRIOL; CALCIUM; DIABETES MELLITUS, TYPE 1; FEMALE; IMMUNOTHERAPY, ADOPTIVE; INSULIN; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED NOD; T-LYMPHOCYTES, REGULATORY;

EID: 0028357305     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF00403372     Document Type: Article

References (40)

1. Breeding of a non-obese diabetic strain of mice
2. Type I diabetes. A chronic autoimmune disease of humans, mouse and rat
3. Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type I (insulin-dependent) diabetes mellitus
4. Immunopathogenesis of diabetes mellitus
5. Vitamin D and the immune system
6. The immunobiology of vitamin D
7. 1,25-dihydroxyvitamin D3 receptors in human leukocytes
8. 1,25 dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes
9. 1,25-Dihydroxy-vitamin D3 inhibits antigen-induced T cells activation
10. Regulation of lymphokine production and human T lymphocyte activation by 1,25 dihydroxy-vitamin D3
11. Comparison of the effects of 1,25 dihydroxyvitamin D3 on T lymphocyte subpopulations
12. 1α, 25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes
13. Calcitriol inhibits the PHA-induced production of IL-2 and IFN-gamma and the proliferation of human peripheral blood leukocytes while enhancing the surface expression of HLA class II molecules
14. 1,25-Dihydroxyvitamin D3 enhances the generation of non specific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR
15. Immunomodulatory role of 1,25-dihydroxyvitamin D3
16. Decreased accessory cell function and costimulatory activity by 1,25-dihydroxyvitamin D3-treated monocytes
17. In vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis
18. 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis
19. 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice
20. Diabetes and low Ca-P diet have opposite effects on adult and fetal bone mineral metabolism
21. Defective activation of T suppressor cell function in nonobese diabetic mice
22. Immunological aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity
23. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice
24. Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1.2 antibody
25. Preventive effect of monoclonal anti-L3T4 antibody on the development of diabetes in NOD mice
26. Preventive effects of cyclosporine on diabetes in NOD mice
27. Preventive effect of a new immunosuppressant FK-506 on insulitis and diabetes in non-obese diabetic mice
28. Immunostimulation circumvents diabetes in NOD/Lt mice
29. Immunomodulating properties of 1,25-dihydroxyvitamin D3
30. Newly identified actions of the vitamin D endocrine system
31. Clinical counterpart: vitamin D: new actions, new analogs, new therapeutic potential
32. Effects of cyclosporin A on human lymphocyte response in vitro
33. Effect of calcitriol on the secretion of prostaglandin E2, IL-1 and tumor necrosis factor alpha by human monocytes
34. The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males
35. T cell mediated inhibition of the transfer of autoimmune diabetes in NOD mice
36. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo
37. Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity
38. New vitamin D3 analogues with potent effects on cell growth regulation and immune responses: structure-activity studies
39. A new vitamin D analogue with potent effects on cell-mediated immune responses in vitro
40. Prevention of immunological disorders in MRL/I mice by a new synthetic analogue of vitamin D3: 22oxa-1α,25-Dihydroxyvitamin D3